Sara Membribes-Coca
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Is there a future for Trop-2-targeted ADCs in urothelial carcinoma?
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 19, 2026
VEGF-TKI Outcomes in Metastatic Renal Cell Carcinoma According to Prior Immune Checkpoint Inhibitor or VEGF-TKI: A Scoping Review and Exploratory Analysis.
Journal: Cancers
Published: December 30, 2025
Does Adjuvant Immune Checkpoint Inhibition Therapy Have a Future in Operable Bladder Cancer?
Journal: European urology focus
Published: December 10, 2025
KIM-1 in Advanced Papillary and Clear Cell Renal Cell Carcinoma.
Journal: European urology
Published: December 08, 2025
KIM-1 in Advanced Papillary and Clear Cell Renal Cell Carcinoma.
Journal: European urology
Published: December 08, 2025
Towards biomarker-driven therapies for urothelial carcinoma.
Journal: Nature reviews. Clinical oncology
Published: October 21, 2025
"Biomarker analyses from randomized trials in clear cell renal cell carcinoma".
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 26, 2025
Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade.
Journal: NPJ precision oncology
Published: November 13, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026